RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 November 2008
Ann Clin Biochem 2008;45:616
doi:10.1258/acb.2008.008066
© 2008 Association for Clinical Biochemistry

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
acb.2008.008066v1
45/6/616    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, H A
Right arrow Articles by Wolffenbuttel, B H R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Letters

Interference from heterophilic antibodies in seven current TSH assays

Interference from heterophilic antibodies (often referred to as HAMA, although strictly this pertains only to antibodies to mouse immunoglobulins) in immunometric assays is well recognized,1,2 but some variants have striking properties that makes them still worth reporting.

When interference is suspected, the measurement should be repeated after dilution, and/or assessed by an immunoassay of different origin using different antibodies.

The first case concerned a patient who was moderately suspected of thyroid disease (normal free T4 level of 17.1 pmol/L and elevated TSH 118 mIU/L, Roche Modular, normal values 1.5–3.5 mIU/L). The TSH diluted in a linear fashion up to 20 times. The measurement was repeated in another laboratory giving TSH 25.2 mIU/L (Abbott Architect, normal values 0.4–4.0 mIU/L) but on this occasion abnormal dilution behaviour was noted. After removal of IgG by Protein G affinity chromatography, as described previously,3 a TSH of 2.7 mIU/L was found. The sample was distributed to other laboratories who tested for TSH with five further assay methods different from the previous two. In all cases spuriously elevated TSH values of variable apparent concentrations were found which seemed unrelated to the assay format (Table 1). It must be noted that some of the between-method differences were too small to raise suspicion. Dilution tests also gave variable results. Where tested (Perkin-Elmer DELFIA), dilution in mouse serum did not improve dilution behaviour, the use of Scantibodies ‘Blocking tubes’ was ineffective.


View this table:
[in this window]
[in a new window]

 
Table 1 Apparent TSH levels in undiluted patient serum and after dilution by a factor 5 (occasionally 4 or 6)

 
The second case concerns a female patient referred with dysphagia and a cystic thyroid gland. Neither signs of malignancy nor hypothyroidism were found. The TSH was greatly increased (48 mIU/L, non-linear dilution) with normal free T4 (13.2 pmol/L). Again, it was not possible to remove heterophilic antibodies using the Scantibodies ‘Blocking tubes.’ Immunoelectrophoresis with fluorescence detection using the Eu-labelled second antibody from the DELFIA TSH-assay showed an abnormal peak of the IgM-immunoglobulin class. After removal of the IgM antibodies, the remaining TSH had a concentration of 3.0 mIU/L.

We conclude that interference by heterophilic antibodies may escape detection if not extensively evaluated. Neither a normal dilution test nor similar results by two different assay methods exclude the presence of interference. Furthermore, screening for only IgG antibodies may give a false negative result, since interference can be due to IgM-antibodies as well. As interferences in TSH-assays are rare,4 the above-mentioned cases show the importance of good communication between clinics and laboratories.

H A Ross1, P P C A Menheere2 (on behalf of the Endocrinology Section of SKML [Dutch Foundation for Quality Assessment in Clinical Laboratories]), C M G Thomas1, A H Mudde3, M Kouwenberg3, B H R Wolffenbuttel4


1 Department of Chemical Endocrinology, Radboud University, Nijmegen Medical Centre, Nijmegen; 2 Department of Clinical Chemistry, University Hospital Maastricht, Maastricht; 3 Department of Internal Medicine, Slingeland Hospital, Doetinchem; 4 Department of Endocrinology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands


    REFERENCES
Go to previous sectionTop
 REFERENCES
 

  1. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942–56[Abstract/Free Full Text]
  2. Ismail AAA, Barth JH, Walker PL, Cawood M. Interference in immunoassay is an underestimated problem. Ann Clin Biochem 2002;39:366–73[Abstract/Free Full Text]
  3. Koper NP, Thomas CM, Massuger LF, Segers MF, Olthaar AJ, Verbeek AL. Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography. Clin Chem Lab Med 1998;36:23–8[Medline]
  4. Ismail AAA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr WA. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results. Clin Chem 2002;48:2023–9[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A A A Ismail
Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know
J. Clin. Pathol., August 1, 2009; 62(8): 673 - 678.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
D J Halsall, E English, and V K Chatterjee
Interference from heterophilic antibodies in TSH assays
Ann Clin Biochem, July 1, 2009; 46(4): 345 - 346.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
A. C Heijboer, R. G Ijzerman, A. A Bouman, and M. A Blankenstein
Two cases of antiruthenium antibody interference in Modular free thyroxine assay
Ann Clin Biochem, May 1, 2009; 46(3): 263 - 264.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
acb.2008.008066v1
45/6/616    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, H A
Right arrow Articles by Wolffenbuttel, B H R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

MDU Exam Doctor